Connect with us

Health

Ponatinib identified as a potent inhibitor of SARS-CoV2-induced cytokine storm – News-Medical.Net

Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor…

Published

on

Article feature image

To date, vaccination efforts have commenced stemming the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Alongside vaccine campaigns, scientists race to find effective drugs to combat the infection.
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the N-terminal domain (NTD) -mediated cytokine…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
A lab leak in Wuhan remains a ‘viable’ theory for the coronavirus’ origin, an international group of scientists says – Business Insider Australia
Teens, young adults who report e-cigarette use have increased odds of asthma – Healio